Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Interest Expenses (2023 - 2025)

Bioregenx's Interest Expenses history spans 3 years, with the latest figure at $82147.0 for Q4 2025.

  • Quarterly results put Interest Expenses at $82147.0 for Q4 2025, down 1.92% from a year ago — trailing twelve months through Dec 2025 was $299578.0 (up 3.07% YoY), and the annual figure for FY2025 was $299578.0, up 3.07%.
  • Interest Expenses for Q4 2025 was $82147.0 at Bioregenx, up from $72106.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $83756.0 in Q4 2024 to a low of $45193.0 in Q4 2023.
  • The 3-year median for Interest Expenses is $69319.5 (2024), against an average of $65124.2.
  • The sharpest move saw Interest Expenses surged 85.33% in 2024, then decreased 1.92% in 2025.
  • Year by year, Interest Expenses stood at $45193.0 in 2023, then surged by 85.33% to $83756.0 in 2024, then decreased by 1.92% to $82147.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $82147.0, $72106.0, and $71086.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.